

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 5.15348322 |
| 2 | embryonic process involved in female pregnancy (GO:0060136) | 4.24220700 |
| 3 | cellular extravasation (GO:0045123) | 3.90567332 |
| 4 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.80514209 |
| 5 | positive regulation of p38MAPK cascade (GO:1900745) | 3.80369668 |
| 6 | hemidesmosome assembly (GO:0031581) | 3.47243488 |
| 7 | detection of molecule of bacterial origin (GO:0032490) | 3.46107790 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 3.41522352 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.35279614 |
| 10 | negative regulation of interleukin-8 production (GO:0032717) | 3.29837924 |
| 11 | regulation of cholesterol homeostasis (GO:2000188) | 3.25958968 |
| 12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21771411 |
| 13 | germinal center formation (GO:0002467) | 3.17208123 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.15773742 |
| 15 | protein carboxylation (GO:0018214) | 3.15773742 |
| 16 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12495268 |
| 17 | growth hormone receptor signaling pathway (GO:0060396) | 3.06955098 |
| 18 | regulation of p38MAPK cascade (GO:1900744) | 3.05463833 |
| 19 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.01333765 |
| 20 | neutrophil mediated immunity (GO:0002446) | 2.99638323 |
| 21 | mRNA transcription (GO:0009299) | 2.96759826 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.92304395 |
| 23 | detection of other organism (GO:0098543) | 2.91084716 |
| 24 | skin morphogenesis (GO:0043589) | 2.90288323 |
| 25 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.89074667 |
| 26 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.79399017 |
| 27 | ovulation (GO:0030728) | 2.79039827 |
| 28 | negative regulation of protein autophosphorylation (GO:0031953) | 2.78274205 |
| 29 | T-helper 1 type immune response (GO:0042088) | 2.77139220 |
| 30 | desmosome organization (GO:0002934) | 2.76732595 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 2.75780871 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 2.75780871 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.75780871 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.75780871 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.75780871 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 2.75780871 |
| 37 | phospholipid efflux (GO:0033700) | 2.74108518 |
| 38 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.72995949 |
| 39 | reverse cholesterol transport (GO:0043691) | 2.72295991 |
| 40 | detection of external biotic stimulus (GO:0098581) | 2.71833426 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 2.70986241 |
| 42 | positive regulation of interferon-alpha production (GO:0032727) | 2.70606845 |
| 43 | interferon-gamma secretion (GO:0072643) | 2.70533981 |
| 44 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.70398554 |
| 45 | complement activation, alternative pathway (GO:0006957) | 2.68153678 |
| 46 | regulation of bile acid biosynthetic process (GO:0070857) | 2.67786019 |
| 47 | myeloid leukocyte mediated immunity (GO:0002444) | 2.67644903 |
| 48 | fibrinolysis (GO:0042730) | 2.66648320 |
| 49 | neutrophil activation (GO:0042119) | 2.66571985 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.66401834 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.65945872 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 2.64076418 |
| 53 | granulocyte activation (GO:0036230) | 2.63398994 |
| 54 | tryptophan catabolic process (GO:0006569) | 2.63015963 |
| 55 | indole-containing compound catabolic process (GO:0042436) | 2.63015963 |
| 56 | indolalkylamine catabolic process (GO:0046218) | 2.63015963 |
| 57 | tryptophan metabolic process (GO:0006568) | 2.62912756 |
| 58 | negative regulation of lipid storage (GO:0010888) | 2.62816721 |
| 59 | cellular response to arsenic-containing substance (GO:0071243) | 2.61145473 |
| 60 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.60870273 |
| 61 | urea metabolic process (GO:0019627) | 2.60585286 |
| 62 | urea cycle (GO:0000050) | 2.60585286 |
| 63 | detection of biotic stimulus (GO:0009595) | 2.59761151 |
| 64 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57433505 |
| 65 | cellular glucuronidation (GO:0052695) | 2.57087495 |
| 66 | aromatic amino acid family catabolic process (GO:0009074) | 2.56936134 |
| 67 | regulation of protein activation cascade (GO:2000257) | 2.56689327 |
| 68 | regulation of interferon-alpha production (GO:0032647) | 2.56682693 |
| 69 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.56492445 |
| 70 | L-phenylalanine catabolic process (GO:0006559) | 2.56492445 |
| 71 | high-density lipoprotein particle remodeling (GO:0034375) | 2.56390878 |
| 72 | pinocytosis (GO:0006907) | 2.55791547 |
| 73 | kynurenine metabolic process (GO:0070189) | 2.55194003 |
| 74 | mannose metabolic process (GO:0006013) | 2.54835401 |
| 75 | lung vasculature development (GO:0060426) | 2.54723829 |
| 76 | cellular response to growth hormone stimulus (GO:0071378) | 2.54511562 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 2.53194319 |
| 78 | regulation of gamma-delta T cell activation (GO:0046643) | 2.52148792 |
| 79 | intestinal cholesterol absorption (GO:0030299) | 2.52090507 |
| 80 | negative regulation of fatty acid transport (GO:2000192) | 2.51543764 |
| 81 | microglial cell activation (GO:0001774) | 2.50004412 |
| 82 | regulation of fibrinolysis (GO:0051917) | 2.49779935 |
| 83 | negative regulation of fibrinolysis (GO:0051918) | 2.48700913 |
| 84 | response to progesterone (GO:0032570) | 2.48469071 |
| 85 | acylglycerol homeostasis (GO:0055090) | 2.48180386 |
| 86 | triglyceride homeostasis (GO:0070328) | 2.48180386 |
| 87 | apoptotic cell clearance (GO:0043277) | 2.47685351 |
| 88 | establishment of endothelial barrier (GO:0061028) | 2.47197468 |
| 89 | low-density lipoprotein particle clearance (GO:0034383) | 2.47168832 |
| 90 | regulation of complement activation (GO:0030449) | 2.47010202 |
| 91 | plasma lipoprotein particle clearance (GO:0034381) | 2.46992525 |
| 92 | trophectodermal cell differentiation (GO:0001829) | 2.46721658 |
| 93 | phospholipid homeostasis (GO:0055091) | 2.46629216 |
| 94 | neutrophil chemotaxis (GO:0030593) | 2.45871871 |
| 95 | cellular response to ethanol (GO:0071361) | 2.45305839 |
| 96 | detection of bacterium (GO:0016045) | 2.45198286 |
| 97 | cell adhesion mediated by integrin (GO:0033627) | 2.45049138 |
| 98 | regulation of triglyceride catabolic process (GO:0010896) | 2.44254578 |
| 99 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.43903632 |
| 100 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.43758531 |
| 101 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.43666517 |
| 102 | iron ion import (GO:0097286) | 2.43354457 |
| 103 | lipoprotein metabolic process (GO:0042157) | 2.42874233 |
| 104 | intestinal epithelial cell development (GO:0060576) | 2.42874026 |
| 105 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.42601826 |
| 106 | L-phenylalanine metabolic process (GO:0006558) | 2.42601826 |
| 107 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.42129278 |
| 108 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.41788556 |
| 109 | endothelial cell chemotaxis (GO:0035767) | 2.41624650 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 2.41522742 |
| 111 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.41022035 |
| 112 | wound healing, spreading of epidermal cells (GO:0035313) | 2.40911328 |
| 113 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.40578024 |
| 114 | neutrophil migration (GO:1990266) | 2.39003331 |
| 115 | response to laminar fluid shear stress (GO:0034616) | 2.38089593 |
| 116 | transcytosis (GO:0045056) | 2.37974605 |
| 117 | surfactant homeostasis (GO:0043129) | 2.36945731 |
| 118 | response to host (GO:0075136) | 2.36773598 |
| 119 | response to host defenses (GO:0052200) | 2.36773598 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.36773598 |
| 121 | positive regulation of macrophage cytokine production (GO:0060907) | 2.36188869 |
| 122 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.35909613 |
| 123 | positive regulation of cholesterol transport (GO:0032376) | 2.35570100 |
| 124 | positive regulation of sterol transport (GO:0032373) | 2.35570100 |
| 125 | regulation of macrophage cytokine production (GO:0010935) | 2.33588546 |
| 126 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.33529116 |
| 127 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.32800311 |
| 128 | positive regulation of interleukin-6 production (GO:0032755) | 2.32375798 |
| 129 | positive regulation of cholesterol efflux (GO:0010875) | 2.32282960 |
| 130 | acute-phase response (GO:0006953) | 2.31847921 |
| 131 | chemical homeostasis within a tissue (GO:0048875) | 2.31294334 |
| 132 | positive regulation of blood coagulation (GO:0030194) | 2.30596564 |
| 133 | positive regulation of hemostasis (GO:1900048) | 2.30596564 |
| 134 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.30464302 |
| 135 | response to host immune response (GO:0052572) | 2.30464302 |
| 136 | response to muramyl dipeptide (GO:0032495) | 2.29386158 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.29122247 |
| 138 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.28839083 |
| 139 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.28648322 |
| 140 | nitrogen cycle metabolic process (GO:0071941) | 2.28479353 |
| 141 | bile acid and bile salt transport (GO:0015721) | 2.28469646 |
| 142 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.28101575 |
| 143 | regulation of interleukin-6 production (GO:0032675) | 2.28029784 |
| 144 | regulation of cholesterol storage (GO:0010885) | 2.27964304 |
| 145 | hormone catabolic process (GO:0042447) | 2.26794608 |
| 146 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.26234489 |
| 147 | histone H3-K36 demethylation (GO:0070544) | 2.26044623 |
| 148 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.25225858 |
| 149 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.25225858 |
| 150 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.25220988 |
| 151 | positive regulation of extracellular matrix organization (GO:1903055) | 2.24387229 |
| 152 | positive regulation of astrocyte differentiation (GO:0048711) | 2.23708056 |
| 153 | macrophage activation (GO:0042116) | 2.23308159 |
| 154 | regulation of leukocyte degranulation (GO:0043300) | 2.23065054 |
| 155 | radial glial cell differentiation (GO:0060019) | 2.22111799 |
| 156 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.21408005 |
| 157 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.21308608 |
| 158 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.21308608 |
| 159 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.20406253 |
| 160 | alpha-linolenic acid metabolic process (GO:0036109) | 2.20019217 |
| 161 | regulation of integrin activation (GO:0033623) | 2.19796219 |
| 162 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.19726642 |
| 163 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.19726642 |
| 164 | positive regulation of coagulation (GO:0050820) | 2.19582498 |
| 165 | regulation of necroptotic process (GO:0060544) | 2.18829567 |
| 166 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.18651955 |
| 167 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.18540374 |
| 168 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.18469455 |
| 169 | plasma lipoprotein particle assembly (GO:0034377) | 2.18452988 |
| 170 | complement activation, classical pathway (GO:0006958) | 2.18193832 |
| 171 | positive regulation of interferon-beta production (GO:0032728) | 2.17284562 |
| 172 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.17271183 |
| 173 | cholesterol efflux (GO:0033344) | 2.16959923 |
| 174 | atrioventricular valve morphogenesis (GO:0003181) | 2.16847520 |
| 175 | response to protozoan (GO:0001562) | 2.16777888 |
| 176 | peptide catabolic process (GO:0043171) | 2.16231344 |
| 177 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.16033571 |
| 178 | oligosaccharide catabolic process (GO:0009313) | 2.15828340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.29238694 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.15470430 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.53364407 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.40135357 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.24205120 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.24145263 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.10900155 |
| 8 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.09549609 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.07988681 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.89731174 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.65759502 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.51746385 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41527490 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41314882 |
| 15 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38562514 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.31112281 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.30423982 |
| 18 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.25202611 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17910662 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17687221 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05431037 |
| 22 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02326020 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.01831363 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.01067574 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96169699 |
| 26 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93653871 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90648242 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.84330746 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.81609785 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.76992365 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.76575713 |
| 32 | * MYC_22102868_ChIP-Seq_BL_Human | 1.71924021 |
| 33 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67880841 |
| 34 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67405779 |
| 35 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64935760 |
| 36 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63809483 |
| 37 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.63799415 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62642557 |
| 39 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61398591 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58056166 |
| 41 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52365666 |
| 42 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.52072699 |
| 43 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.52072699 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50059032 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49292571 |
| 46 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46446179 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46059299 |
| 48 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.41896501 |
| 49 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.41442460 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40217734 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40082310 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39104007 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37663713 |
| 54 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37125285 |
| 55 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36131712 |
| 56 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.33772876 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33417794 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32859873 |
| 59 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31251694 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30861886 |
| 61 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26998500 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23893278 |
| 63 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23426117 |
| 64 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22221293 |
| 65 | * MAF_26560356_Chip-Seq_TH1_Human | 1.21735642 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19837411 |
| 67 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.18691985 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18585558 |
| 69 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18156898 |
| 70 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17424508 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17118745 |
| 72 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16491230 |
| 73 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16388305 |
| 74 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.15939108 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15114383 |
| 76 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14897224 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.14314209 |
| 78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12786636 |
| 79 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12249828 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11045839 |
| 81 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09240888 |
| 82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08608284 |
| 83 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08464145 |
| 84 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07992530 |
| 85 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.07647488 |
| 86 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07619861 |
| 87 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06523231 |
| 88 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06291285 |
| 89 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.04954622 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04651862 |
| 91 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04589845 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03725756 |
| 93 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02324349 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02132681 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02120832 |
| 96 | * MYB_26560356_Chip-Seq_TH2_Human | 1.01788242 |
| 97 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01326117 |
| 98 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01287936 |
| 99 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00920995 |
| 100 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.00386614 |
| 101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99788072 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99746913 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99333629 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98693920 |
| 105 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97664184 |
| 106 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96790957 |
| 107 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95552460 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94480512 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94309192 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93607643 |
| 111 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.92562633 |
| 112 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.92562633 |
| 113 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.92562633 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92161072 |
| 115 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89812319 |
| 116 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87889001 |
| 117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86564939 |
| 118 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86356546 |
| 119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85859818 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85596192 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.84605172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 3.05321842 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.03222971 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 2.77302464 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.70500465 |
| 5 | MP0005365_abnormal_bile_salt | 2.52293514 |
| 6 | MP0003724_increased_susceptibility_to | 2.50109938 |
| 7 | MP0005360_urolithiasis | 2.49843349 |
| 8 | MP0003436_decreased_susceptibility_to | 2.43686957 |
| 9 | MP0005451_abnormal_body_composition | 2.27134598 |
| 10 | MP0003303_peritoneal_inflammation | 2.21019454 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.06726636 |
| 12 | MP0009840_abnormal_foam_cell | 2.06717405 |
| 13 | MP0003252_abnormal_bile_duct | 2.01717564 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 1.89536779 |
| 15 | MP0005076_abnormal_cell_differentiation | 1.83808626 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 1.79826752 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 1.77313684 |
| 18 | MP0003453_abnormal_keratinocyte_physiol | 1.70923247 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.70132221 |
| 20 | MP0001853_heart_inflammation | 1.68591105 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.68326640 |
| 22 | MP0004947_skin_inflammation | 1.68206633 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66662731 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.64489852 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.63014643 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.58254613 |
| 27 | MP0003828_pulmonary_edema | 1.57904649 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.57415197 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.52753762 |
| 30 | MP0002060_abnormal_skin_morphology | 1.52429170 |
| 31 | MP0001879_abnormal_lymphatic_vessel | 1.51025819 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.50361973 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.50361973 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.48845252 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.46772687 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.45620033 |
| 37 | MP0009278_abnormal_bone_marrow | 1.45024764 |
| 38 | MP0005023_abnormal_wound_healing | 1.44462328 |
| 39 | MP0001851_eye_inflammation | 1.42697223 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.42116904 |
| 41 | MP0005083_abnormal_biliary_tract | 1.41773757 |
| 42 | MP0002933_joint_inflammation | 1.41319964 |
| 43 | MP0005248_abnormal_Harderian_gland | 1.39032716 |
| 44 | MP0002796_impaired_skin_barrier | 1.37717320 |
| 45 | MP0000537_abnormal_urethra_morphology | 1.37608147 |
| 46 | MP0000609_abnormal_liver_physiology | 1.34348268 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.33393525 |
| 48 | MP0000685_abnormal_immune_system | 1.31142818 |
| 49 | MP0002419_abnormal_innate_immunity | 1.30321706 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.30255637 |
| 51 | MP0003045_fibrosis | 1.29340782 |
| 52 | MP0005310_abnormal_salivary_gland | 1.27264291 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.26448726 |
| 54 | MP0005275_abnormal_skin_tensile | 1.23836368 |
| 55 | MP0009764_decreased_sensitivity_to | 1.23682005 |
| 56 | MP0002132_abnormal_respiratory_system | 1.22841382 |
| 57 | MP0001216_abnormal_epidermal_layer | 1.22820508 |
| 58 | MP0002098_abnormal_vibrissa_morphology | 1.22496101 |
| 59 | MP0001873_stomach_inflammation | 1.20351685 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.20100008 |
| 61 | MP0005390_skeleton_phenotype | 1.19515314 |
| 62 | MP0004510_myositis | 1.18866554 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.17138996 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.15224865 |
| 65 | MP0001819_abnormal_immune_cell | 1.14557025 |
| 66 | MP0000383_abnormal_hair_follicle | 1.14301079 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.12133979 |
| 68 | MP0000767_abnormal_smooth_muscle | 1.11527464 |
| 69 | MP0003448_altered_tumor_morphology | 1.09946651 |
| 70 | MP0006082_CNS_inflammation | 1.09484261 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.09005496 |
| 72 | MP0003195_calcinosis | 1.08612644 |
| 73 | MP0005387_immune_system_phenotype | 1.07996595 |
| 74 | MP0001790_abnormal_immune_system | 1.07996595 |
| 75 | MP0005670_abnormal_white_adipose | 1.07903716 |
| 76 | MP0003941_abnormal_skin_development | 1.07873074 |
| 77 | MP0009053_abnormal_anal_canal | 1.07802474 |
| 78 | MP0002166_altered_tumor_susceptibility | 1.05480181 |
| 79 | MP0005000_abnormal_immune_tolerance | 1.04015597 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 1.02736396 |
| 81 | MP0004883_abnormal_blood_vessel | 1.02444898 |
| 82 | MP0003279_aneurysm | 1.01436871 |
| 83 | MP0003075_altered_response_to | 1.01143988 |
| 84 | MP0010678_abnormal_skin_adnexa | 1.01078173 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01035414 |
| 86 | MP0009115_abnormal_fat_cell | 0.98868790 |
| 87 | MP0005164_abnormal_response_to | 0.98330154 |
| 88 | MP0009785_altered_susceptibility_to | 0.97628554 |
| 89 | MP0005375_adipose_tissue_phenotype | 0.96555954 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.95892342 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.95716069 |
| 92 | MP0002928_abnormal_bile_duct | 0.95590088 |
| 93 | MP0005025_abnormal_response_to | 0.95589459 |
| 94 | MP0000858_altered_metastatic_potential | 0.95578034 |
| 95 | MP0000516_abnormal_urinary_system | 0.95158986 |
| 96 | MP0005367_renal/urinary_system_phenotyp | 0.95158986 |
| 97 | MP0001881_abnormal_mammary_gland | 0.94529209 |
| 98 | MP0002452_abnormal_antigen_presenting | 0.94267195 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.92019596 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.91738696 |
| 101 | MP0009384_cardiac_valve_regurgitation | 0.90927865 |
| 102 | MP0000249_abnormal_blood_vessel | 0.90508049 |
| 103 | MP0002405_respiratory_system_inflammati | 0.89663999 |
| 104 | MP0004272_abnormal_basement_membrane | 0.89176463 |
| 105 | MP0008469_abnormal_protein_level | 0.89097950 |
| 106 | MP0002396_abnormal_hematopoietic_system | 0.89022418 |
| 107 | MP0008004_abnormal_stomach_pH | 0.88726336 |
| 108 | MP0001800_abnormal_humoral_immune | 0.88597419 |
| 109 | MP0005166_decreased_susceptibility_to | 0.88307748 |
| 110 | MP0001191_abnormal_skin_condition | 0.88067206 |
| 111 | MP0002168_other_aberrant_phenotype | 0.87340681 |
| 112 | MP0008961_abnormal_basal_metabolism | 0.86800294 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.86144599 |
| 114 | MP0000716_abnormal_immune_system | 0.86113981 |
| 115 | MP0000627_abnormal_mammary_gland | 0.85641855 |
| 116 | MP0003868_abnormal_feces_composition | 0.84955447 |
| 117 | MP0005508_abnormal_skeleton_morphology | 0.84101664 |
| 118 | MP0000465_gastrointestinal_hemorrhage | 0.83521921 |
| 119 | MP0008260_abnormal_autophagy | 0.82028885 |
| 120 | MP0003795_abnormal_bone_structure | 0.81708678 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.81504289 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.81251422 |
| 123 | MP0002723_abnormal_immune_serum | 0.81113387 |
| 124 | MP0002006_tumorigenesis | 0.80948857 |
| 125 | MP0003091_abnormal_cell_migration | 0.79804981 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.79653991 |
| 127 | MP0000343_altered_response_to | 0.79197409 |
| 128 | MP0002398_abnormal_bone_marrow | 0.78837896 |
| 129 | MP0005464_abnormal_platelet_physiology | 0.78475655 |
| 130 | MP0005647_abnormal_sex_gland | 0.78339921 |
| 131 | MP0002009_preneoplasia | 0.77362894 |
| 132 | MP0005409_darkened_coat_color | 0.75648692 |
| 133 | MP0005334_abnormal_fat_pad | 0.74907579 |
| 134 | MP0008057_abnormal_DNA_replication | 0.74249614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myocardial infarction (HP:0001658) | 4.22418970 |
| 2 | Xanthomatosis (HP:0000991) | 3.78054492 |
| 3 | Complement deficiency (HP:0004431) | 3.60144381 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.41177572 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.39875585 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.35811856 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 3.35625525 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.31785090 |
| 9 | Prostate neoplasm (HP:0100787) | 3.27828547 |
| 10 | Abnormality of the fingertips (HP:0001211) | 3.23448481 |
| 11 | Abnormality of complement system (HP:0005339) | 3.18826553 |
| 12 | Joint hemorrhage (HP:0005261) | 3.11307856 |
| 13 | Esophageal varix (HP:0002040) | 3.11189783 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.06473575 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 3.02422108 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.00856174 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 2.99068277 |
| 18 | Glomerulonephritis (HP:0000099) | 2.95618519 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 2.94376020 |
| 20 | Milia (HP:0001056) | 2.91223079 |
| 21 | Onycholysis (HP:0001806) | 2.89032462 |
| 22 | Myositis (HP:0100614) | 2.86559567 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 2.85463573 |
| 24 | Optic neuritis (HP:0100653) | 2.85463573 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83286710 |
| 26 | Subacute progressive viral hepatitis (HP:0006572) | 2.76935541 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.74958817 |
| 28 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70886823 |
| 29 | Hematochezia (HP:0002573) | 2.69017839 |
| 30 | Thick nail (HP:0001805) | 2.67599877 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.61368604 |
| 32 | Pigmentary retinal degeneration (HP:0001146) | 2.59865283 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.58977238 |
| 34 | Atrophic scars (HP:0001075) | 2.55830975 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.52406989 |
| 36 | Sparse lateral eyebrow (HP:0005338) | 2.52081584 |
| 37 | Hypolipoproteinemia (HP:0010981) | 2.49386528 |
| 38 | Alopecia of scalp (HP:0002293) | 2.48532355 |
| 39 | Dysmetric saccades (HP:0000641) | 2.46185553 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.46062367 |
| 41 | Malnutrition (HP:0004395) | 2.38532338 |
| 42 | Vascular calcification (HP:0004934) | 2.37840167 |
| 43 | Nephritis (HP:0000123) | 2.36919965 |
| 44 | Broad face (HP:0000283) | 2.36518343 |
| 45 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.36208682 |
| 46 | Neonatal hypoglycemia (HP:0001998) | 2.35782109 |
| 47 | Epidermoid cyst (HP:0200040) | 2.31614995 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.31540469 |
| 49 | Axonal loss (HP:0003447) | 2.31304713 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 2.28977380 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.28964317 |
| 52 | Vitreoretinal degeneration (HP:0000655) | 2.27716412 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.25948835 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.25948835 |
| 55 | Plantar hyperkeratosis (HP:0007556) | 2.25947492 |
| 56 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.24006634 |
| 57 | Hyperglycemia (HP:0003074) | 2.21919252 |
| 58 | Lip pit (HP:0100267) | 2.21839385 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.20468489 |
| 60 | Tetraparesis (HP:0002273) | 2.19829239 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.15610746 |
| 62 | Hypobetalipoproteinemia (HP:0003563) | 2.15286427 |
| 63 | Vasculitis (HP:0002633) | 2.15063312 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.14580432 |
| 65 | Aortic aneurysm (HP:0004942) | 2.12551512 |
| 66 | Loss of speech (HP:0002371) | 2.12131471 |
| 67 | Colitis (HP:0002583) | 2.11256635 |
| 68 | Recurrent bacterial skin infections (HP:0005406) | 2.10680580 |
| 69 | Hypoglycemic coma (HP:0001325) | 2.10156442 |
| 70 | Abnormality of the axillary hair (HP:0100134) | 2.09842058 |
| 71 | Abnormality of secondary sexual hair (HP:0009888) | 2.09842058 |
| 72 | Fat malabsorption (HP:0002630) | 2.09798866 |
| 73 | Recurrent skin infections (HP:0001581) | 2.08672777 |
| 74 | Pustule (HP:0200039) | 2.08266165 |
| 75 | Viral hepatitis (HP:0006562) | 2.06596864 |
| 76 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.04047146 |
| 77 | Cellulitis (HP:0100658) | 2.03627427 |
| 78 | Curly hair (HP:0002212) | 2.03439279 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.02396468 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 2.01927721 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00373637 |
| 82 | Increased IgE level (HP:0003212) | 2.00229812 |
| 83 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.99539921 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98593580 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 1.98593580 |
| 86 | Depressed nasal tip (HP:0000437) | 1.96993863 |
| 87 | Autoimmune hemolytic anemia (HP:0001890) | 1.96908670 |
| 88 | Distal lower limb amyotrophy (HP:0008944) | 1.96098292 |
| 89 | Gingival bleeding (HP:0000225) | 1.95647375 |
| 90 | Amyloidosis (HP:0011034) | 1.94296320 |
| 91 | Abnormality of the prostate (HP:0008775) | 1.93786039 |
| 92 | Diaphragmatic weakness (HP:0009113) | 1.93075637 |
| 93 | Increased serum ferritin (HP:0003281) | 1.92033127 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91466299 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91466299 |
| 96 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91466299 |
| 97 | Abnormality of the nasal septum (HP:0000419) | 1.90838610 |
| 98 | Arterial thrombosis (HP:0004420) | 1.90543225 |
| 99 | Periodontitis (HP:0000704) | 1.89791028 |
| 100 | Premature rupture of membranes (HP:0001788) | 1.87853611 |
| 101 | Mitral stenosis (HP:0001718) | 1.87444394 |
| 102 | Hemorrhage of the eye (HP:0011885) | 1.87301341 |
| 103 | Pulmonary infiltrates (HP:0002113) | 1.87220958 |
| 104 | Polycythemia (HP:0001901) | 1.86878939 |
| 105 | Vacuolated lymphocytes (HP:0001922) | 1.86402701 |
| 106 | Menorrhagia (HP:0000132) | 1.86354090 |
| 107 | Bulbar palsy (HP:0001283) | 1.86336088 |
| 108 | Aneurysm (HP:0002617) | 1.86234584 |
| 109 | Urethral obstruction (HP:0000796) | 1.85575066 |
| 110 | Epiphyseal dysplasia (HP:0002656) | 1.84530247 |
| 111 | Conjugated hyperbilirubinemia (HP:0002908) | 1.84462501 |
| 112 | Septate vagina (HP:0001153) | 1.84142144 |
| 113 | Recurrent fungal infections (HP:0002841) | 1.83810934 |
| 114 | Recurrent viral infections (HP:0004429) | 1.83660052 |
| 115 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.83542263 |
| 116 | Protuberant abdomen (HP:0001538) | 1.83451438 |
| 117 | Submucous cleft hard palate (HP:0000176) | 1.83170062 |
| 118 | Recurrent abscess formation (HP:0002722) | 1.82625667 |
| 119 | Hemoptysis (HP:0002105) | 1.82545301 |
| 120 | Hypercholesterolemia (HP:0003124) | 1.79523515 |
| 121 | Cheilitis (HP:0100825) | 1.79228582 |
| 122 | Gingivitis (HP:0000230) | 1.79140308 |
| 123 | Micronodular cirrhosis (HP:0001413) | 1.78761358 |
| 124 | Osteomyelitis (HP:0002754) | 1.77454353 |
| 125 | Meningitis (HP:0001287) | 1.77185587 |
| 126 | Asymmetric septal hypertrophy (HP:0001670) | 1.76994463 |
| 127 | Abdominal distention (HP:0003270) | 1.76445217 |
| 128 | Increased connective tissue (HP:0009025) | 1.74931462 |
| 129 | Peritonitis (HP:0002586) | 1.74513707 |
| 130 | Cerebral aneurysm (HP:0004944) | 1.74512014 |
| 131 | Keratoconjunctivitis (HP:0001096) | 1.73780431 |
| 132 | Fragile nails (HP:0001808) | 1.71851405 |
| 133 | Acute myeloid leukemia (HP:0004808) | 1.71495180 |
| 134 | Gangrene (HP:0100758) | 1.71002580 |
| 135 | Urticaria (HP:0001025) | 1.70386455 |
| 136 | Progressive visual loss (HP:0000529) | 1.69387578 |
| 137 | Abnormal tarsal ossification (HP:0008369) | 1.69334882 |
| 138 | Anal stenosis (HP:0002025) | 1.69230471 |
| 139 | Polygenic inheritance (HP:0010982) | 1.68827932 |
| 140 | Increased CSF protein (HP:0002922) | 1.68433419 |
| 141 | Abnormal foot bone ossification (HP:0010675) | 1.67960135 |
| 142 | Mitral valve prolapse (HP:0001634) | 1.67903672 |
| 143 | Hypoplasia of dental enamel (HP:0006297) | 1.67579491 |
| 144 | Obstructive sleep apnea (HP:0002870) | 1.67128990 |
| 145 | Hypoplastic ischia (HP:0003175) | 1.66984376 |
| 146 | Exocrine pancreatic insufficiency (HP:0001738) | 1.66946208 |
| 147 | Slow saccadic eye movements (HP:0000514) | 1.65939353 |
| 148 | Abnormality of purine metabolism (HP:0004352) | 1.65846763 |
| 149 | Mucopolysacchariduria (HP:0008155) | 1.65826637 |
| 150 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65826637 |
| 151 | Vascular tortuosity (HP:0004948) | 1.64856488 |
| 152 | Spondylolisthesis (HP:0003302) | 1.63839074 |
| 153 | Arterial tortuosity (HP:0005116) | 1.63445349 |
| 154 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63414653 |
| 155 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63414653 |
| 156 | Alveolar cell carcinoma (HP:0006519) | 1.63363594 |
| 157 | Rectal prolapse (HP:0002035) | 1.62929861 |
| 158 | Flat acetabular roof (HP:0003180) | 1.62601905 |
| 159 | Abnormal platelet function (HP:0011869) | 1.62598229 |
| 160 | Impaired platelet aggregation (HP:0003540) | 1.62598229 |
| 161 | Acanthosis nigricans (HP:0000956) | 1.62274354 |
| 162 | Abnormality of the ischium (HP:0003174) | 1.61650372 |
| 163 | Abnormality of macrophages (HP:0004311) | 1.61609455 |
| 164 | Hypoglycemic seizures (HP:0002173) | 1.61468155 |
| 165 | Hepatocellular carcinoma (HP:0001402) | 1.61458585 |
| 166 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.61117218 |
| 167 | Orchitis (HP:0100796) | 1.60776670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.57942879 |
| 2 | EPHA2 | 3.55648855 |
| 3 | FGFR4 | 2.89742434 |
| 4 | TGFBR2 | 2.79080028 |
| 5 | MAPK15 | 2.78446830 |
| 6 | EPHA3 | 2.74221649 |
| 7 | MAP3K3 | 2.74079670 |
| 8 | EPHB1 | 2.56574467 |
| 9 | AKT3 | 2.44352791 |
| 10 | MAP3K14 | 2.36538704 |
| 11 | PRPF4B | 2.15309609 |
| 12 | LATS1 | 2.14638088 |
| 13 | TNK2 | 2.00602437 |
| 14 | RIPK1 | 1.99252298 |
| 15 | IRAK3 | 1.92985675 |
| 16 | SIK1 | 1.92853447 |
| 17 | TBK1 | 1.89955054 |
| 18 | RIPK4 | 1.86571759 |
| 19 | MAP3K10 | 1.66987105 |
| 20 | MAP2K2 | 1.66083200 |
| 21 | TYK2 | 1.63469303 |
| 22 | CHUK | 1.57946818 |
| 23 | FGFR3 | 1.56562635 |
| 24 | FRK | 1.51727162 |
| 25 | TAOK3 | 1.50232649 |
| 26 | IKBKE | 1.45495804 |
| 27 | PIM2 | 1.44366407 |
| 28 | INSRR | 1.42448745 |
| 29 | IKBKB | 1.41072375 |
| 30 | RPS6KA4 | 1.39743639 |
| 31 | EEF2K | 1.37122077 |
| 32 | PTK6 | 1.36598941 |
| 33 | BMPR2 | 1.36441970 |
| 34 | NLK | 1.33593133 |
| 35 | BRD4 | 1.29355014 |
| 36 | JAK1 | 1.29142597 |
| 37 | CDK12 | 1.27420514 |
| 38 | TRIB3 | 1.27070921 |
| 39 | NEK9 | 1.26294860 |
| 40 | BRSK2 | 1.25980300 |
| 41 | MAP3K13 | 1.24946726 |
| 42 | MAP3K2 | 1.22237030 |
| 43 | STK10 | 1.19935317 |
| 44 | MARK2 | 1.15843404 |
| 45 | MST4 | 1.15683569 |
| 46 | FER | 1.13975563 |
| 47 | MST1R | 1.10657513 |
| 48 | CDK6 | 1.10648569 |
| 49 | IRAK1 | 1.09845781 |
| 50 | TAOK2 | 1.06761609 |
| 51 | CAMK1D | 1.04953187 |
| 52 | STK24 | 1.04582516 |
| 53 | CSK | 1.04265143 |
| 54 | MAP4K1 | 1.03457075 |
| 55 | SIK3 | 1.03198853 |
| 56 | GSK3A | 1.01814602 |
| 57 | ICK | 0.99553652 |
| 58 | DMPK | 0.98299602 |
| 59 | HIPK2 | 0.97557010 |
| 60 | JAK3 | 0.97116807 |
| 61 | NUAK1 | 0.95809071 |
| 62 | JAK2 | 0.94376078 |
| 63 | SMG1 | 0.93662095 |
| 64 | MATK | 0.93107328 |
| 65 | PTK2 | 0.92116889 |
| 66 | EPHB2 | 0.91668282 |
| 67 | MAP2K3 | 0.90900266 |
| 68 | MAP3K1 | 0.90646547 |
| 69 | YES1 | 0.90134699 |
| 70 | IRAK4 | 0.89504060 |
| 71 | ERBB2 | 0.88871749 |
| 72 | KDR | 0.88533922 |
| 73 | CDC42BPA | 0.85392742 |
| 74 | LMTK2 | 0.84718524 |
| 75 | PDGFRB | 0.81781444 |
| 76 | MAPK7 | 0.79245527 |
| 77 | ITK | 0.78376153 |
| 78 | ZAP70 | 0.77681679 |
| 79 | PRKG2 | 0.77290917 |
| 80 | LATS2 | 0.77243122 |
| 81 | TIE1 | 0.77123276 |
| 82 | SGK3 | 0.74314851 |
| 83 | CDK9 | 0.73901549 |
| 84 | PIK3CG | 0.73854379 |
| 85 | TGFBR1 | 0.71329318 |
| 86 | FGFR2 | 0.71248973 |
| 87 | FGR | 0.68143345 |
| 88 | PRKD2 | 0.67352197 |
| 89 | MAPKAPK2 | 0.65864266 |
| 90 | PIM1 | 0.65344739 |
| 91 | MAPK4 | 0.64791364 |
| 92 | CSF1R | 0.64436790 |
| 93 | CAMK1G | 0.62818966 |
| 94 | STK38L | 0.62455671 |
| 95 | PDPK1 | 0.62272974 |
| 96 | DYRK1B | 0.61506631 |
| 97 | MKNK2 | 0.61336815 |
| 98 | TAOK1 | 0.59113604 |
| 99 | STK3 | 0.58669541 |
| 100 | PDGFRA | 0.57936698 |
| 101 | BMX | 0.57918302 |
| 102 | MAP3K7 | 0.57731970 |
| 103 | HCK | 0.57573496 |
| 104 | TEC | 0.56742449 |
| 105 | ERBB4 | 0.56634730 |
| 106 | MTOR | 0.54817991 |
| 107 | MAP3K11 | 0.54281150 |
| 108 | MOS | 0.53707915 |
| 109 | NEK6 | 0.49006336 |
| 110 | PKN2 | 0.48830995 |
| 111 | PAK4 | 0.48535353 |
| 112 | LRRK2 | 0.48451596 |
| 113 | PIK3CA | 0.48010470 |
| 114 | MET | 0.46784916 |
| 115 | SGK2 | 0.46537166 |
| 116 | EGFR | 0.46501157 |
| 117 | PRKAA2 | 0.46362375 |
| 118 | GRK7 | 0.45956261 |
| 119 | MELK | 0.45818934 |
| 120 | PAK2 | 0.45008007 |
| 121 | PDK2 | 0.44225752 |
| 122 | TTN | 0.43220380 |
| 123 | MAPK12 | 0.42313283 |
| 124 | RPS6KA6 | 0.42205904 |
| 125 | TRPM7 | 0.41424152 |
| 126 | BLK | 0.40616001 |
| 127 | RPS6KL1 | 0.40475067 |
| 128 | ABL1 | 0.40362628 |
| 129 | IGF1R | 0.40030329 |
| 130 | ERBB3 | 0.38004444 |
| 131 | RPS6KA1 | 0.37104830 |
| 132 | CDK3 | 0.36111237 |
| 133 | IRAK2 | 0.35741923 |
| 134 | RPS6KC1 | 0.34839272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91516102 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61715507 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.53064545 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.45708236 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.43540272 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.33360128 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07215191 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76219818 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.74426167 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67932905 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60228714 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.59064814 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.48557429 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40644388 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38045127 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37572934 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34587359 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.34273732 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.32868661 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28907783 |
| 21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27154734 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.26869152 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25844352 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24756884 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23641383 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19909848 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.19262223 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19239391 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17907092 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.13509673 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12879450 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.11858361 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08423707 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08372549 |
| 35 | Adherens junction_Homo sapiens_hsa04520 | 1.08274188 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07257895 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06937656 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06813869 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04250142 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03807346 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.03664525 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03021404 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01996640 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01305366 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 0.99994232 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98076849 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97860102 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97048042 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96546228 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96154491 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.93508198 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 0.92817393 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92578904 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92277362 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90127951 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89644189 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88755092 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88261480 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88204186 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87802537 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86746636 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.83780601 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82565640 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.82521079 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82307488 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82283034 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81706777 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81702838 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81386835 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81343510 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80945324 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80942995 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80543201 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79234556 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78976914 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78918197 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78865750 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77576205 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77391377 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.77078833 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.76876127 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.76816302 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.76756143 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76034702 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75902940 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75755872 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.74545215 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74463846 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73484526 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73414985 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.72673252 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72360586 |
| 93 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71643944 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.70253465 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69281700 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.68794390 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68415840 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68010899 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67909514 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.67195173 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66413894 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.66201996 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.65723285 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65015528 |
| 105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64757193 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.63091601 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.63043994 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62371844 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62062315 |
| 110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60207095 |
| 111 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60186745 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.60126734 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.59925254 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59296148 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59147590 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58961043 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57897268 |
| 118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57697706 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57475229 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57110413 |
| 121 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56934465 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56690214 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56284941 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56237975 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56097024 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55791018 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55517620 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54094425 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53708305 |
| 130 | Prostate cancer_Homo sapiens_hsa05215 | 0.53243076 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53212158 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52917050 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51850582 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51661431 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.51403464 |
| 136 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51320837 |
| 137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50700364 |
| 138 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50203350 |
| 139 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49544374 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49501729 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.45785794 |
| 142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44404833 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44189221 |
| 144 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43532073 |
| 145 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42974326 |

